Cardiovascular Disease
Daily polypill plus aspirin lowers risk for CVD, death
Adults at intermediate CV risk assigned a polypill plus aspirin were 31% less likely to experience a CV event or death compared with those assigned double placebo over a nearly 5-year period, according to new data from the TIPS-3 trial.
VIDEO: RA and the ‘lipid paradox’ need awareness, understanding
In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, spoke with Healio about a cross-sectional study presented at ACR 2020 that delved into the “lipid paradox.”
Single preoperative dose of tranexamic acid may decrease blood loss after TJA
Top in cardiology: Nighttime BP, proinflammatory foods
Nighttime BP fluctuations may be an independent predictor of future stroke, coronary artery disease and heart failure, according to recent study results. It was the top story in cardiology last week.
Long-term CVD monitoring needed for children with Kawasaki disease
The risk for cardiovascular disease persists for 10 years after initial hospitalization among children with Kawasaki disease, according to data presented at the ACR Convergence 2020 virtual meeting.
Kidney donation may increase hypertension risk but shows no link to cardiovascular disease
A study of living kidney donors in Denmark found that while donation was associated with a greater risk for hypertension, it did not appear to increase the likelihood of donors developing cardiovascular disease.
Guideline: Measure lipids for all adults with endocrine conditions
All adults with endocrine disorders should undergo measurement of cholesterol and triglyceride levels to better manage their cardiovascular risk, according to a new clinical practice guideline from the Endocrine Society.
Weight fluctuation increases risk for cardiovascular events in patients with RA
Recent weight changes, as well as high variability in weight, predict cardiovascular events in patients with rheumatoid arthritis, according to data published in Arthritis Care & Research.
Minority participation remains low in U.S. diabetes cardiovascular outcome trials
Diabetes cardiovascular outcome trials are enrolling a lower percentage of minority participants than what is reflective of United States’ population, according to a presenter at the virtual Cardiometabolic Health Congress.
Reproductive profiles in women may indicate future CVD risk
Several reproductive factors, including preeclampsia, preterm birth and early menopause, may increase risk for CVD in women, researchers found.